Form 4: Maze Therapeutics Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Phillips Courtney, GC and Corp. Secretary of Maze Therapeutics, Inc., sold 3,993 shares of common stock on September 2, 2026.

Summary

  • Open-market sale: disposed of 1,738 Common Stock at $26.38 ($45,841) on September 2, 2026; holds 9,262 after (Direct).
  • Open-market sale: disposed of 243 Common Stock at $27.12 ($6,590) on September 2, 2026; holds 9,019 after (Direct).
  • Open-market sale: disposed of 1,990 Common Stock at $26.01 ($51,766) on September 3, 2026; holds 7,029 after (Direct).
  • Open-market sale: disposed of 22 Common Stock at $25.78 ($567) on September 3, 2026; holds 7,007 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $104,766 of stock on the open market.

Insider Transactions

Phillips Courtney — Officer (GC and Corp. Secretary)

DateTransactionSecuritySharesPriceValueHeld After
2026-09-02Open-market saleCommon Stock1,738$26$45.8K9,262
2026-09-02Open-market saleCommon Stock243$27$6.6K9,019
2026-09-03Open-market saleCommon Stock1,990$26$51.8K7,029
2026-09-03Open-market saleCommon Stock22$26$5677,007

Key Dates

DateDescription
2026-09-02Open-market sale (1,738 shares)
2026-09-02Open-market sale (243 shares)
2026-09-03Open-market sale (1,990 shares)
2026-09-03Open-market sale (22 shares)

Keywords

insider transaction, Form 4, MAZE, Maze Therapeutics, Inc., bearish, Phillips Courtney

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.